Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Neurocritical Care|December 15, 2018
ABO Blood Type and Hematoma Expansion After Intracerebral Hemorrhage: An Exploratory AnalysisDavid Roh, Andrew Martin, Chung-Huan Sun, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 4, 2016
Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist DevicesVeli K Topkara, Robert J Knotts, Douglas L Jennings, et al.Vascular Medicine (London, England)|March 22, 2023
Association between Hispanic or Latino ethnicity and pulmonary embolism severity, management, and in-hospital outcomesDaniel J Snyder, Robert S Zilinyi, Mahesh V Madhavan, et al.The Journal of Clinical Investigation|January 22, 2020
Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusionRichard O Francis, Angelo D'Alessandro, Andrew Eisenberger, et al.Blood Neoplasia|October 23, 2025
Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemiaEvelyn H Orlando, Patrick Gould, Brian Cuzzo, et al.The Journal of Clinical Investigation|December 13, 2016
Prolonged red cell storage before transfusion increases extravascular hemolysisFrancesca Rapido, Gary M Brittenham, Sheila Bandyopadhyay, et al.Trials|November 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.Trials|June 10, 2020
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.Vascular Medicine (London, England)|April 5, 2021
Pulmonary Embolism Response Team utilization during the COVID-19 pandemicMatthew T Finn, Shawn Gogia, Joseph J Ingrassia, et al.Trials|June 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.Pageof 5